Prozac's Successor?

Research being presented at the European Congress of Neuropsychopharmacology in Istanbul has presented results that indicates a new antidepressant is more effective than fluoxetine (Prozac). Agomelatine to be marketed as Valdoxan has also fewer side effects according to the authors of the study

Read the article in depth